Cancer survivors had a greater risk of reduced ambulatory function, which was associated with an increased risk of death, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American ...
Mar 4, 2021
0
4
A machine learning-based tool was able to predict the risk of malignancy among patients presenting with multiple pulmonary nodules and outperformed human experts, previously validated mathematical models, and a previously ...
Feb 24, 2021
0
1
Among patients with lymphoma admitted to the hospital for severe COVID-19, those treated with B-cell-depleting therapies within the previous 12 months had an increased risk of prolonged hospital stay and death, according ...
Feb 4, 2021
0
3
Compared with patients with cancer who were not on active treatment, those receiving chemotherapy did not have an increased risk for developing COVID-19, according to data presented at AACR Virtual Meeting: COVID-19 and Cancer, ...
Feb 4, 2021
0
0
Esophageal adenocarcinoma is occurring more frequently in adults under age 50, and these younger adults are more likely to be diagnosed at advanced stages, according to a study published in Cancer Epidemiology, Biomarkers ...
Dec 16, 2020
0
2
A large meta-analysis of breast cancer survivors of childbearing age indicated that they are less likely than the general public to get pregnant, and they face higher risk of certain complications such as preterm labor. However, ...
Dec 9, 2020
0
1
Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy after breast-conserving surgery had higher rates of local recurrence but similar 10-year survival rates when compared to patients ...
Dec 9, 2020
0
3
Women who receive mastectomy and reconstructive surgery as part of breast cancer treatment may face the risk of developing persistent use of opioids and sedative-hypnotic drugs, according to data presented at the 2020 San ...
Dec 9, 2020
0
3
Early circulating tumor cell dynamics were associated with overall survival in patients with metastatic breast cancer, according to a meta-analysis presented at the 2020 San Antonio Breast Cancer Symposium, held Dec. 8-11.
Dec 9, 2020
0
2
Extended follow-up data from the phase III monarchE trial showed that adding the cyclin-dependent kinase (CDK) inhibitor abemaciclib (Verzenio) to standard adjuvant endocrine therapy continued to improve invasive disease-free ...
Dec 9, 2020
0
1
